Abstract
Clinical data on male neuromyelitis optica spectrum (NMO) patients remain limited to date. To analyze clinical characteristics, therapeutic responses, and outcomes in Chinese male NMOSD patients. We retrospectively assessed clinical, demographic, treatment, and outcome data of male patients with NMOSD. We identified 52 male patients among 471 NMOSD patients. Male patients had more frequent optic neuritis (ON) attacks and less frequent myelitisthan female patients. No-remission rates of high-dose intravenous steroid therapy were higher in male patients than in female patients. Male NMOSD patients had different clinical characteristics and worse response to high-dose intravenous steroid therapy than female patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
